Explore Stanford technologies available for licensing:

Stanford researchers have designed a light-driven bimetallic alloyed plasmonic photocatalyst that can both effectively and selectively catalyze heterogenous hydrogenation.

Stanford scientists have developed novel, inhibitory chimeric antigen receptor T cells (iCARs) based on immunoreceptor tyrosine-based inhibitory motif (ITIM)-containing signaling domains that can inhibit standard activating CAR (aCARs) activity (see figure* below).

Stanford inventors have developed a multiomic methodology for identifying and measuring non-structural proteins and RNA species from human hair. This approach will reveal unique biomarker profiles for wellness or diseases that are not currently identified.

Researchers at Stanford have developed a comb-based analog coherent receiver for wavelength-division multiplexed (WDM) optical data center links.

Stanford inventors have engineered an adeno-associated virus (AAV) variant on the existing LK03 platform that enables this highly efficient primate-specific serotype for use in rodent preclinical studies.

Researchers at Stanford have developed a CRISPR-based system to degrade viral RNA, with potential applications as both an anti-viral therapeutic and a prophylactic treatment against influenza, SARS-CoV-2, and other viruses.

Researchers at Stanford have developed a potentially curative treatment strategy for alpha-thalassemia, one of the most common autosomal recessive disorders in the world involving the genes HBA1 and/or HBA2.

Stanford inventors have engineered microbial systems to form a broad range of aliphatic and aromatic polyesters.

Stanford researchers developed a technology that efficiently identifies combinations of genetic interventions with lasting, effective therapeutic functions by constructing genetic perturbation libraries containing the desired combination of phenotypes extracted from each cell.

Researchers at Stanford have developed light-cleavable cloaking agents to control and study RNA activity in vitro and in vivo.

Stanford researchers have developed method for targeted application focused ultrasound to peripheral nerves to suppress acute pain.

Stanford researchers led by Dr. Arun Majumdar have developed photocatalysts combining transport- and reaction-selective nanostructures for direct methanol production.

Cancers including breast, lung, colon and prostate account for almost ten million deaths worldwide every year. The main cause of cancer deaths is metastasis, which is the propensity of cancer cells to spread throughout the body.

Adeno-associated virus (AAV) vectored products are currently leading candidates for gene therapy applications with multiple approved products and many more in clinical trials.

The blood-brain barrier is a huge challenge when it comes to the delivery of therapeutic proteins to treat genetic diseases, injury, and neurodegenerative diseases.